Publications
5808 Results
- Journal / Conference
- Journal of Thoracic Oncology 8(12):1519-1528;
- Year
- 2013
- Research Committee(s)
- Lung
- PMID
- PMID24189513
- PMC
- PMC4072123
- Study Number(s)
- S0536
Phase II trial of carboplatin, paclitaxel, cetuximab and bevacizumab followed by cetuximab and bevacizumab in advanced non-small cell lung cancer: SWOG 0536
- Journal / Conference
- Clinical Cancer Research 19(23):6624-32;
- Year
- 2013
- Research Committee(s)
- Lymphoma
- PMID
- PMID24130072
- PMC
- PMC3872052
- Study Number(s)
- S0016
A comparative analysis of prognostic factor models for follicular lymphoma based on a phase III trial of CHOP-Rituximab vs CHOP + 131Iodine-Tositumomab
- Journal / Conference
- Blood 121(13):2424-2431;
- Year
- 2013
- Research Committee(s)
- Leukemia
- PMID
- PMID23325837
- PMC
- PMC3612855
- Study Number(s)
- S0106, S0112, SWOG-8600, SWOG-9031, SWOG-9034 (EST-3489) (CALGB-9120), SWOG-9333, SWOG-9500, S9617, S9918
Significance of FAB subclassification of "acute myeloid leukemia, not otherwise specified" in the 2008 WHO classification: analysis of 5,848 newly diagnosed patients
- Journal / Conference
- New England Journal of Medicine, Apr 4; 368(14):1314-1325;
- Year
- 2013
- Research Committee(s)
- Genitourinary
- PMID
- PMID23550669
- PMC
- PMC3682658
- Study Number(s)
- SWOG-9346
Intermittent versus continuous androgen deprivation in prostate cancer
- Journal / Conference
- Journal of the American Medical Association, 309(6):578-586;
- Year
- 2013
- Research Committee(s)
- Prevention, Screening, and and Surveillance
- PMID
- PMID23403682
- PMC
- PMC3697935
- Study Number(s)
- S0701
Risk of recurrent Helicobacter pylori infection 1 year after initial eradication therapy in 7 Latin American communities
- Journal / Conference
- Cancer Causes and Control 24(2):209-215;
- Year
- 2013
- Research Committee(s)
- Prevention, Screening, and and Surveillance
- PMID
- PMID23263777
- PMC
- PMC3645498
- Study Number(s)
- S0701
Epidemiology of Helicobacter pylori infection in six Latin American countries (SWOG trial S0701)
- Journal / Conference
- Cancer 119(3):593-601;
- Year
- 2013
- Research Committee(s)
- Cancer Control
- PMID
- PMID22893105
- PMC
- PMC3502695
- Study Number(s)
- SWOG-9217
Projecting prostate mortality in the PCPT and REDUCE chemoprevention trials
- Journal / Conference
- Leukemia & Lymphoma 54(2):252-254
- Year
- 2013
- Research Committee(s)
- Leukemia
- PMID
- PMID22897733
The impact of initial fludarabine therapy on transformation to richter's syndrome or prolymphocytic leukemia in patients with chronic lymphocytic leukemia: analysis of an intergroup trial (CALGB 9011)
- Journal / Conference
- Journal of Clinical Oncology 31(13):1662-1668;
- Year
- 2013
- Research Committee(s)
- Lymphoma
- PMID
- PMID23478060
- PMC
- PMC3635682
Phase III randomized study of rituximab/carmustine, etoposide, cytarabine, melphalan (BEAM) compared with 131-iodine tositumomab/BEAM with autologous stem cell transplantation for relapsed diffuse large b-cell lymphoma (DLBCL): results from the Blood and Marrow Transplant Clinical Trials Netword (BMT CTN) 0401 trial
- Journal / Conference
- Annals of Oncology 24(6):1587-1593;
- Year
- 2013
- Research Committee(s)
- Lymphoma
- PMID
- PMID23504948
- PMC
- PMC3660082
- Study Number(s)
- S0213